A ground-breaking study, conducted by researchers from the University of Virginia, Mount Sinai, the University of Michigan, ...

Prostate cancer is one of the most prevalent cancers among men, with the American Cancer Society estimating that ...

Prostate cancer is the second leading cause of cancer death among American men. A recent study, conducted by researchers from the University of Virginia, Mount Sinai, the University of Michigan, the ...

There is a limit of eight, 30-minute appointments. To schedule an appointment, or inquire further, call the hospital’s social ...

Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET ...

Graves disease and cancer were associated with each other, as Graves disease diagnosis was linked to increased risks for ovarian and prostate cancers.

Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, ...

A guideline panel indirectly studied cardiotoxicity among advanced prostate cancer treatments (mHSPC, mCRPC, CRPC).

A team at the University of Cordoba and IMIBIC tests the protective effect of a fermented black garlic extract against ...

TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.

The phase 3 trial AMPLIFY study plans to test the diagnostic performance of 64Cu-SAR-bisPSMA PET/CT imaging in approximately ...

The survival rate of men with prostate cancer who had their entire prostate gland removed immediately after the tumor was ...